Skip to main content


Page 6 of 41

  1. The contribution of chronic kidney disease (CKD) to mortality in diabetic patients is unclear. This study aimed to explore the association between diabetics with CKD and mortality in middle-aged and elderly pe...

    Authors: Xihong Liao, Ke Shi, Yumeng Zhang, Xiaoxu Huang, Ning Wang, Ling Zhang and Xiaohuan Zhao
    Citation: Diabetology & Metabolic Syndrome 2023 15:122
  2. Observational studies have reported an inverse association of type 2 diabetes (T2D) with thoracic aortic aneurysm (TAA). However, the causality of the association has not been established yet. The present stud...

    Authors: Yiran Zhang, Yongxin Li, Xiaoyi Dai, Haokai Lin and Liang Ma
    Citation: Diabetology & Metabolic Syndrome 2023 15:120
  3. Long noncoding RNAs (LncRNAs) have been identified to play an important role in diabetes. The aim of the present study was to determine the expression and function of small nucleolar RNA host gene 16 (SNHG16) ...

    Authors: Linjuan Huang, Shengxi Xiong, Hanshuang Liu, Ranran Zhang, Ying Wu and Xiaolei Hu
    Citation: Diabetology & Metabolic Syndrome 2023 15:119
  4. Gestational diabetes mellitus (GDM) represents the main metabolic alteration during pregnancy. The available methods for diagnosing GDM identify women when the disease is established, and pancreatic beta-cell ...

    Authors: Melissa Razo-Azamar, Rafael Nambo-Venegas, Noemí Meraz-Cruz, Martha Guevara-Cruz, Isabel Ibarra-González, Marcela Vela-Amieva, Jaime Delgadillo-Velázquez, Xanic Caraza Santiago, Rafael Figueroa Escobar, Felipe Vadillo-Ortega and Berenice Palacios-González
    Citation: Diabetology & Metabolic Syndrome 2023 15:116
  5. Diabetes is a metabolic disorder of glucose homeostasis in which β cell destruction occurs silently and is detected mainly when symptoms appear. In the last few years, it has emerged a great interest in develo...

    Authors: Teresa María Linares-Pineda, Carolina Gutiérrez-Repiso, Nerea Peña-Montero, María Molina-Vega, Fuensanta Lima Rubio, María Suárez Arana, Francisco J. Tinahones, María José Picón-César and Sonsoles Morcillo
    Citation: Diabetology & Metabolic Syndrome 2023 15:115
  6. Pathophysiological mechanisms underlying sex-based differences in diabetes remain poorly understood. Mitochondrial metabolite methylmalonic acid (MMA) accumulation reflects mitochondrial dysfunction which is i...

    Authors: Shanjie Wang, JunChen Guo, Xiaoxuan Liu, Wei Tian, Yiying Zhang, Ye Wang, Yige Liu, Mingyan E. and Shaohong Fang
    Citation: Diabetology & Metabolic Syndrome 2023 15:114
  7. Sodium-glucose cotransporter-2 (SGLT-2) inhibitors therapies were reported to affect adipose tissue distribution. However, the available evidence about the effect of SGLT-2 inhibitor on adipose tissue is contr...

    Authors: Xianghong Wang, Niujian Wu, Chuanchuan Sun, Donghua Jin and Hongyun Lu
    Citation: Diabetology & Metabolic Syndrome 2023 15:113
  8. The Triglyceride and Glucose (TyG) index has been found to have a strong correlation with the recurrence of acute ischemic stroke (AIS) and poor patient outcomes. Nevertheless, the relationship between the TyG...

    Authors: Jia Wang, Hao Tang, Xiaokun Wang, Jiarong Wu, Jiaqi Gao, Shuang Diao and Yun Wu
    Citation: Diabetology & Metabolic Syndrome 2023 15:112
  9. The purpose of the study was to compare the efficacy of two novel obesity indices, lipid accumulation product (LAP) and visceral adiposity index (VAI), with traditional obesity indices in predicting early-onse...

    Authors: Chen-Ying Lin, Jing-Bo Li, Fan Wu, Jun-Jia Wang, Hao-Hua An, Hui-Na Qiu, Long-Fei Xia, Yao-Shuang Li, Ya-Jie Zhai, Chun-Jun Li and Jing-Na Lin
    Citation: Diabetology & Metabolic Syndrome 2023 15:111
  10. Clinical comparisons of angiotensin receptor–neprilysin inhibitors (ARNI) and sodium–glucose cotransporter 2 inhibitors (SGLT2i) treatment in patients with HFrEF and T2DM are limited. This study evaluated the ...

    Authors: Ming-Lung Tsai, Yuan Lin, Ming-Shyan Lin, Tzu-Hsien Tsai, Ning-I Yang, Chao-Yung Wang, I-Chang Hsieh, Ming-Jui Hung and Tien-Hsing Chen
    Citation: Diabetology & Metabolic Syndrome 2023 15:110
  11. In the general population, metabolic syndrome (MetS) is associated with increased risk of cognitive impairment, including global and specific cognitive domains. These associations are not well studied in patie...

    Authors: Yuqi Yang, Qian Li, Yanjun Long, Jing Yuan and Yan Zha
    Citation: Diabetology & Metabolic Syndrome 2023 15:108
  12. A Mediterranean-style diet (MED) can promote people lengthen the span of life and avoid atherosclerotic cardiovascular disease (ASCVD) in primary prevention. Metabolic syndrome (MetS) can significantly reduce ...

    Authors: Hongxuan Fan, Yongle Wang, Zhaoyu Ren, Xuchang Liu, Jianqi Zhao, Yalin Yuan, Xiaoning Fei, Xiaosu Song, Fengqin Wang and Bin Liang
    Citation: Diabetology & Metabolic Syndrome 2023 15:107
  13. Bilirubin has been found to protect against overt atherosclerotic diseases, but to date, few studies have investigated the effects of bilirubin especially within the normal range on lower limb atherosclerosis....

    Authors: Cui-Chun Zhao, Jun-Wei Wang, Ming-Yun Chen, Jiang-Feng Ke, Mei-Fang Li and Lian-Xi Li
    Citation: Diabetology & Metabolic Syndrome 2023 15:105
  14. Although diabetes is reportedly associated with the occurrence of acute pancreatitis (AP), the risk of AP according to the duration and severity of diabetes is not yet clear. We aimed to investigate the risk o...

    Authors: In Rae Cho, Kyung-Do Han, Sang Hyub Lee, Young Hoon Choi, Kwang Hyun Chung, Jin Ho Choi, Namyoung Park, Min Woo Lee, Woo Hyun Paik, Ji Kon Ryu and Yong-Tae Kim
    Citation: Diabetology & Metabolic Syndrome 2023 15:104
  15. Diabetes with co-existing bone fragility or osteoporosis is common in elderly patients, whereas is frequently underestimated.

    Authors: Chieh-Hua Lu, Chien-Hsing Lee, Li-Wei Wu, Chun-Cheng Liao, Sheng-Chiang Su, Jhih-Syuan Liu, Peng-Fei Li, Chia-Luen Huang, Li-Ju Ho, Chien-Ming Lin, Ming-Hsun Lin, Chun-Yung Chang, Yi-Chen Liu, Chih-Ping Lin, An-Che Cheng and Feng-Chih Kuo
    Citation: Diabetology & Metabolic Syndrome 2023 15:103
  16. Diabetes is one of the chronic conditions with a high burden all around the world. Macrovascular and microvascular involvement are among the common mechanisms by which diabetes can impact patients’ lives. Endo...

    Authors: Amirmohammad Khalaji, Amir Hossein Behnoush, Behrad Saeedian, Shaghayegh Khanmohammadi, Zahra Shokri Varniab and Soheil Peiman
    Citation: Diabetology & Metabolic Syndrome 2023 15:102
  17. Human Islet amyloid polypeptide (hIAPP) from pancreatic β cells in the islet of Langerhans has different physiological functions including inhibiting the release of insulin and glucagon. Type 2 diabetes mellit...

    Authors: Mohammed Alrouji, Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou, Marios Papadakis, Hebatallah M. Saad and Gaber El-Saber Batiha
    Citation: Diabetology & Metabolic Syndrome 2023 15:101
  18. Diabetes causes impaired microarterial blood flow, demyelination and neuronal damage, which may lead to cochlear damage and vestibular malfunction. Vestibular evoked myogenic potentials (VEMP) is a simple, rep...

    Authors: Jinying Zhang, Lichao Ye, Xuefeng Bai, Yali Huang, Jiayu Lin and Huapin Huang
    Citation: Diabetology & Metabolic Syndrome 2023 15:100
  19. Metabolic syndrome (MS) represents a cluster of metabolic abnormalities. Insulin resistance is a major component of the syndrome. We analyze in this study the relationship between body fat composition and MS i...

    Authors: Hourfil-Gabin Ntougou Assoumou, Vincent Pichot, Jean-Claude Barthelemy, Sébastien Celle, Arnauld Garcin, Thierry Thomas and Frédéric Roche
    Citation: Diabetology & Metabolic Syndrome 2023 15:98
  20. Arteriosclerosis and non-alcoholic fatty liver disease are major complications of diabetes mellitus. Hyperglycemia, insulin resistance, obesity, and metabolic syndrome are associated with the progression of th...

    Authors: Yuriko Hajika, Yuji Kawaguchi, Kenji Hamazaki and Yasuro Kumeda
    Citation: Diabetology & Metabolic Syndrome 2023 15:97
  21. Proton pump inhibitors (PPIs) are common and widely used for gastrointestinal-related disorders. Lansoprazole is one of PPIs with potential benefits of anti-inflammation, reduced oxidative stress, and anti-dia...

    Authors: Ming-Hsun Lin, Wen‐Tung Wu, Yong-Chen Chen, Tsung-Kun Lin, Yu‐Ching Chou and Chien‐An Sun
    Citation: Diabetology & Metabolic Syndrome 2023 15:96
  22. For patients with diabetes, high-frequency and -amplitude glycemic variability may be more harmful than continuous hyperglycemia; however, there is still a lack of screening indicators that can quickly and eas...

    Authors: Rui Shi, Lei Feng, Yan-Mei Liu, Wen-Bo Xu, Bei-Bei Luo, Ling-Tong Tang, Qian-Ye Bi and Hui-Ying Cao
    Citation: Diabetology & Metabolic Syndrome 2023 15:95
  23. Non-alcoholic fatty liver disease (NAFLD) is associated with atrial fibrillation (AF). Insulin resistance (IR) is the main cause of the high prevalence of AF in NAFLD patients. The triglyceride-glucose index (...

    Authors: Yao Zhang, Leigang Wang, Jiaxin Qi, Bing Yu, Jianqi Zhao, Lin Pang, Wenjing Zhang and Liang Bin
    Citation: Diabetology & Metabolic Syndrome 2023 15:94
  24. Empagliflozin, a sodium–glucose co-transporter 2 inhibitor (SGLT2i), has been reported to significantly reduce the risk of heart failure in multiple clinical studies. However, the underlying mechanisms remain ...

    Authors: Lin Zhang, Heming Zhang, Xiuzhu Xie, Ruping Tie, Xiaolin Shang, Qianqian Zhao, Junjie Xu, Liyuan Jin, Jinying Zhang and Ping Ye
    Citation: Diabetology & Metabolic Syndrome 2023 15:93
  25. As a CGM-derived indicator, ‘time in range’ (TIR) is emerging as a key indicator for accurate assessment of glycaemic control. However, there is few report focusing on the correlation of TIR with albumuria and...

    Authors: Xuguang Jin, Xinyi Yang, Yixin Xu, Jingjing Liang, Chunyan Liu, Qingyu Guo, Wei Wang, Zhouqin Feng, Yanyu Yuan, Hui Zhou, Zhen Zhang, Wenwen Jiang, Yue Liang, Bin Lu, Jiaqing Shao, Yong Zhong…
    Citation: Diabetology & Metabolic Syndrome 2023 15:92
  26. There are few studies and inconsistent findings on the role of sleep-related parameters in the development of metabolic syndrome (MetS) among youths. In this study, we aim to investigate the relationship betwe...

    Authors: Majid Kazemi, Parvin Khalili, Mahsa Kazemi, Hadi Hasani, Marjan Sadeghi and Zahra Jamali
    Citation: Diabetology & Metabolic Syndrome 2023 15:91
  27. Differentiating between type 1 diabetes (T1D) and type 2 diabetes (T2D) can be difficult in adults. The aim of this study was to determine the frequency of diagnostic reclassification from T2D to T1D, the char...

    Authors: Raúl Rodríguez Escobedo, Carmen Lambert, Paula Morales Sánchez, Elías Delgado Álvarez and Edelmiro Menéndez Torre
    Citation: Diabetology & Metabolic Syndrome 2023 15:90
  28. Few studies have examined the relationship between malnutrition, as defined by the Geriatric Nutrition Risk Index (GNRI), and all-cause mortality and cardiovascular mortality events, particularly in persons wi...

    Authors: Xia Shen, Long Yang, Xue Gu, Yuan-Yuan Liu and Lei Jiang
    Citation: Diabetology & Metabolic Syndrome 2023 15:89
  29. Authors: Fei Chen, Jinping Wang, Xiaoping Chen, Liping Yu, Yali An, Qiuhong Gong, Bo Chen, Shuo Xie, Lihong Zhang, Ying Shuai, Fang Zhao, Yanyan Chen, Guangwei Li and Bo Zhang
    Citation: Diabetology & Metabolic Syndrome 2023 15:88

    The original article was published in Diabetology & Metabolic Syndrome 2023 15:62

  30. Finerenone is a third-generation mineralocorticoid receptor antagonists, which has shown good cardiac function improvement in patients with type 2 diabetes in large-scale clinical trials. However, its specific...

    Authors: Tao Jin, Xiangrui Fu, Ming Liu and Fengshuang An
    Citation: Diabetology & Metabolic Syndrome 2023 15:87
  31. Glycogen storage disease type 1b (GSD1b) is an autosomal recessive lysosomal storage disease caused by defective glucose-6-phosphate transporter encoded by SLC37A4 leading to the accumulation of glycogen in va...

    Authors: Latifa Chkioua, Yessine Amri, Chayma Sahli, Ferdawes Ben Rhouma, Amel Ben Chehida, Neji Tebib, Taieb Messaoud, Hassen Ben Abdennebi and Sandrine Laradi
    Citation: Diabetology & Metabolic Syndrome 2023 15:86
  32. Recurrent DKA (rDKA) remains an acute type 1 diabetes complication even in post-insulin era. This study aimed to analyze the predictors and effects of rDKA on the mortality of patients with type 1 diabetes.

    Authors: Sarah S. Santos, Luana A. L. Ramaldes, Patricia M. Dualib, Monica A. L. Gabbay, João R. Sá and Sergio A. Dib
    Citation: Diabetology & Metabolic Syndrome 2023 15:85
  33. Osteoporosis, a chronic complication of diabetes mellitus, is characterized by a reduction in bone mass, destruction of bone microarchitecture, decreased bone strength, and increased bone fragility. Because of...

    Authors: Kairan Bao, Yinghua Jiao, Lei Xing, Fang Zhang and Faming Tian
    Citation: Diabetology & Metabolic Syndrome 2023 15:84
  34. Diabetic autonomic neuropathy (DAN) is a frequent complication in people with diabetes whose screening is often neglected. This study aimed to evaluate DAN through practical tools in people with diabetes in a ...

    Authors: Ana Raquel Souza de Azevedo Vieira, Lara Benigno Porto-Dantas, Flaviene Alves do Prado Romani, Patrícia Souza Carvalho, Rodica Pop-Busui and Hermelinda Cordeiro Pedrosa
    Citation: Diabetology & Metabolic Syndrome 2023 15:83
  35. We examined the longitudinal association between (change in) physical activity (PA) with new onset of five risk factors of metabolic syndrome among 657 middle-aged adults (mean age 44.1 (standard deviation (SD...

    Authors: Laura Cleven, Anna Dziuba, Janina Krell-Roesch, Steffen C. E. Schmidt, Klaus Bös, Darko Jekauc and Alexander Woll
    Citation: Diabetology & Metabolic Syndrome 2023 15:82
  36. Glycemic monitoring has become critical during the COVID-19 pandemic because of poor prognosis in diabetes. Vaccines were key in reducing the spread of infection and disease severity but data were lacking on e...

    Authors: Cheng-Wei Lin, Shih-Yuan Hung and I-Wen Chen
    Citation: Diabetology & Metabolic Syndrome 2023 15:81
  37. Observational studies demonstrated a bidirectional association between type 2 diabetes (T2D) and hypertension, whereas Mendelian randomization (MR) analyses supported the causality from T2D to hypertension but...

    Authors: Haotian Wang, Yuan Li, Weijie Cao, Jie Zhang, Mingyang Cao, Xiaoni Meng, Di Liu and Youxin Wang
    Citation: Diabetology & Metabolic Syndrome 2023 15:80
  38. Hypoglycemia in type 1 diabetes (T1D) is associated with mortality and morbidity, especially when awareness of hypoglycemia is impaired. This study aimed to investigate the protective and risk factors for impa...

    Authors: Naoki Sakane, Ken Kato, Sonyun Hata, Erika Nishimura, Rika Araki, Kunichi kouyama, Masako Hatao, Yuka Matoba, Yuichi Matsushita, Masayuki Domichi, Akiko Suganuma, Seiko Sakane, Takashi Murata and Fei Ling Wu
    Citation: Diabetology & Metabolic Syndrome 2023 15:79
  39. Metabolic syndrome is associated with type 2 diabetes and its prevalence is increasing worldwide in young adults. We aimed to determine whether cumulative exposure to metabolic syndrome is associated with type...

    Authors: Min-Kyung Lee, Jae-Hyuk Lee, Seo Young Sohn, Jiyeon Ahn, Oak-Kee Hong, Mee-Kyoung Kim, Ki-Hyun Baek, Ki-Ho Song, Kyungdo Han and Hyuk-Sang Kwon
    Citation: Diabetology & Metabolic Syndrome 2023 15:78
  40. The transition to metabolically unhealthy obesity (MUO) is driven by the limited expandability of adipose tissue (AT). Familial Partial Lipodystrophy type 2 (FPLD2) is an alternative model for AT dysfunction t...

    Authors: Guillaume Treiber, Marie-Paule Gonthier, Alice Guilleux, Samir Medjane, Oriane Bonfanti, Muriel Cogne, Olivier Meilhac and Estelle Nobecourt
    Citation: Diabetology & Metabolic Syndrome 2023 15:77
  41. Vitamin D supplementation exerts several supporting effects on improving glycemic status, however, results are inconclusive. Thus, in the present study, we aimed to conduct an umbrella of meta-analysis regardi...

    Authors: Vali Musazadeh, Zeynab Kavyani, Naghmeh Mirhosseini, Parvin Dehghan and Mahdi Vajdi
    Citation: Diabetology & Metabolic Syndrome 2023 15:76
  42. To understand the prevalence of hypertension and hyperlipidaemia as well as the current status of glycaemic control and its influencing factors among type 2 diabetes mellitus patients in the community in South...

    Authors: Zhiyu Zhai, Yunou Yang, Guozhen Lin, Weiquan Lin, Jiagang Wu, Xiangyi Liu, Shijia Zhang, Qin Zhou, Hui Liu and Guang Hao
    Citation: Diabetology & Metabolic Syndrome 2023 15:73
  43. N-terminal B-type natriuretic peptide (NT-proBNP) discriminates mortality risk in diabetes mellitus (DM) and in heart failure (HF) populations. Whether DM status modifies the association between NT-proBNP and ...

    Authors: Weida Qiu, Anping Cai, Xiaoju Xiao, Zhiping Gao, Yingqing Feng and Liwen Li
    Citation: Diabetology & Metabolic Syndrome 2023 15:72

New Content Item

The official journal of the Brazilian Diabetes Society.

Annual Journal Metrics

  • 2022 Citation Impact
    4.8 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.476 - SNIP (Source Normalized Impact per Paper)
    1.195 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    87 days submission to accept (Median)

    2023 Usage 
    1,058 Altmetric mentions